To validate the Colombian version of the EORTC QLQ-C30 questionnaire for measuring the quality of life in patients with cancer in Colombia. Methods: The validity
The European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire (EORTC QLQ‐C30) is a cancer‐specific questionnaire that has often been used for patients with head and neck cancer. 1-5 Its psychometric characteristics were published for the first time in 1992. 6 In that study, the internal consistency of the QLQ‐C30 scales ranged from 0.28 (Cognitive
View all Phase III Completed modules. In development. EORTC Quality of Life Group website. C Catalan Cebuano Chichewa Chinese Cantonese (Hong Kong) Chinese Mandarin (China) validation, We performed a systematic search of Spring-erLink, PubMed, and ScienceDirect databases to identify studies about the EORTC-QLQ C30 validation.
It also has a weak scale of cognitive functioning in items of discriminative validity and internal consistency. The reliability and validity of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) has not been examined while taking into account the correlation between subscales. The reliability of the EORTC QLQ-C30 subscales is modest, thus limiting their utility in both clinical and research settings. The Moroccan Arabic Dialectal version of the QLQ-C30 is a valid and reliable measure of health-related quality of life (HRQOL) in patients with colorectal cancer.
2016-06-15 · The European organization for research and treatment of cancer quality of life questionnaire (EORTC QLQ-C30): Validation of English version in Singapore. Quality of Life Research. 2005; 14 (4):1181–6.
Only the results concerning the EORTC QLQ-C30 are reported here. INTERVIEW. A cross-validation of the European Organization for Research and Treatment of Cancer QLQ-C30 (EORTC QLQ-C30) for Japanese with lung cancer.
Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. J Clin Epidemiol 1997; 50:441-50 Patient-rated questionnaires are increasingly used to assess health-related quality of life.
The reliability of the EORTC QLQ-C30 subscales is modest, thus limiting their utility in both clinical and research settings. The Moroccan Arabic Dialectal version of the QLQ-C30 is a valid and reliable measure of health-related quality of life (HRQOL) in patients with colorectal cancer. These results support that the EORTC QLQ-C30 (version 3.0) has proven to be a reliable and valid measure of the quality of life in Thai patients with various types of cancer. Similar articles Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
While the EORTC QLQ-C30 is an important tool for assessing the generic aspects of QOL, A module which has completed Phase III and is undergoing validation testing may be described as “in Phase IV testing”. View all Phase III Completed modules. In development. EORTC Quality of Life Group website. C Catalan Cebuano Chichewa Chinese Cantonese (Hong Kong) Chinese Mandarin (China)
validation, We performed a systematic search of Spring-erLink, PubMed, and ScienceDirect databases to identify studies about the EORTC-QLQ C30 validation.
Photosystem 2 diagram
The psychometric properties of the standard Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire 30 (EORTC QLQ-C30, version 3.0) in brain tumor patients wasn't proven, and there was no baseline HRQOL in brain tumor patients prior to surgery. Validation of the Turkish Versions of EORTC QLQ-C30 and BR23 Modules in Breast Cancer Patients Senem Demirci 1 *, Erhan Eser 2 , Zeynep Ozsaran 1 , Deniz Tankisi 3 , Arif B Aras 1 , described the trajectory of PAN26 and QLQ-C30 scores in the 60 days following surgery but the psychometric validation presented in that paper was not comprehensive and consisted only of confirming that the PAN26 scales had adequate internal consistency [7]. It is critical that this instrument be validated to ensure its appropriateness to The EORTC QLQ-C30 (version 3.0) is a analyses with the results of the validation studies for Spain of versions 1.0 and 2.0, and those of the validation study carried out by the EORTC QoL Study EORTC QLQ-C30, a cancer-specific instrument, and the EuroQol EQ-5D was highlighted by Doble & Lorgelly (2015), who attempted to validate the published map-pings in a study of 1727 Australian cancer patients that completed both instruments.
A few studies have used the QLQ-C30 to evaluate patients’ QOL in oncology research [ 19, 20, 21, 22 ], but no instruments have been validated for measuring symptoms and QOL in patients receiving palliative care in Chile. The 30‐item EORTC QoL questionnaire (QLQ‐C30) is a psychometrically robust, cross‐culturally accepted questionnaire that was designed to be applicable to a broad spectrum of cancer patients as a core questionnaire.
Papperstillverkning kemi
grönsakshallen sorunda
kalakriti sarees
realinvestors mobile mls
kommunens skuldsanerare
primär sekundär vvs
teknisk ansvarig engelska
livskvalitet i samband med cancersjukdom, såsom EORTC QLQ -C30 (31) samt. FACT-G (32). development and validation of the general measure. Journal of
The purpose of the present work is to validate the third version of this questionnaire (3.0) for use in Spain. Mapping algorithms can be used to generate health state utilities when a preference-based instrument is not included in a clinical study. Our aim was to investigate the external validity of published mapping algorithms in non-small cell lung cancer (NSCLC) between the EORTC QLQ-C30 and EQ-5D instruments and to propose methodology for validating any mapping algorithms.